GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
27 Mar, 2026, 02.22 PM IST
India’s weight-loss drugs to get cheaper as semaglutide patent expiresAffordable generic versions of popular weight-loss drugs Wegovy and Ozempic are set to launch in India. This follows the patent expiry of s...
25 Feb, 2026, 03.04 PM IST
Canadian pharmacy platform to offer India-sourced Ozempic to US patientsSaveRxCanada.to, an online pharmacy platform, announced it is now offering Ozempic sourced from India to U.S. patients at significantly low...
09 Jan, 2026, 06.51 AM IST
Delhi HC allows Dr. Reddy’s to export weight-loss drug semaglutide, calls Novo Nordisk’s case ‘weak’The Delhi High Court declined to stay a single-judge order allowing Dr. Reddy's to export its semaglutide, observing Novo Nordisk's appeal ...
12 Dec, 2025, 11.24 AM IST
Delhi HC allows Sun Pharma to manufacture, export its own weight loss drugThe Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...
10 Dec, 2025, 11.56 AM IST
Slimmer price tag helps Wegovy sales gain weightNovo Nordisk has slashed Wegovy prices in India by nearly 40 percent. This move has dramatically increased sales volume by 70 percent in No...
09 Dec, 2025, 12.44 AM IST
Novo Nordisk gears up for December Ozempic launch in India, sources sayDanish drugmaker Novo Nordisk is set to launch its popular diabetes drug Ozempic in India this month. This move aims to capture a significa...
04 Dec, 2025, 10.21 AM IST
HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglut...
03 Dec, 2025, 12.48 AM IST
Weight-loss drug Ozempic to debut in India soonNovo Nordisk will launch Ozempic in India. This injectable drug manages type 2 diabetes and aids weight loss. It enters a competitive marke...
26 Sep, 2025, 11.36 PM IST
Novo Nordisk aims for heavy sales in India with WegovyThe achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescriptio...
24 Jun, 2025, 05.30 AM IST
Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brandNovo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They ...
22 Apr, 2025, 11.50 AM IST
Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...
12 Apr, 2025, 06.00 AM IST
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival loomsNovo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of rival Eli Lil...
03 Dec, 2024, 11.43 AM IST
Ozempic frenzy lures rich Indians to brave the gray marketPeople are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...
19 Jun, 2024, 08.25 AM IST
New study warns of serious side effects from popular weight loss drugs Wegovy and Ozempic, finds they may paralyse stomachA recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterize...
27 May, 2024, 11.04 AM IST
Indiamart working with Novo Nordisk to halt illegal Wegovy salesThe drugmaker's India legal team held discussions with Indiamart's top executives to develop a "framework" for regularly alerting the onlin...
18 Dec, 2023, 07.03 AM IST
Hollywood's blockbuster weight loss drugs are becoming all the rage among affluent IndiansAccording to doctors and fitness experts, queries come in every other day from (well-heeled) patients, asking whether they can take the exp...
17 Oct, 2023, 10.15 AM IST